Implementation and evaluation of comprehensive medication management in telehealth practices

Badowski, Melissa E; Wright, Eric A.; Bainbridge, Jacquelyn; Michienzi, Sarah M; Nichols, Stephanie D.; Turner, Kyle; Wicke, Christine; Awad, John; Thompkins, April; Martin, Randy D.

doi:10.1002/jac5.1210

Cited by 15 publications

(22 citation statements)

References 50 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Telepharmacy is primarily used in community, hospital, and ambulatory care settings to augment pharmacist coverage in rural and medically underserved areas. [20][21][22][23] Outcomes associated with telepharmacy services, particularly when combined with on-site pharmacy services, have been positive and include decreased medication errors, decreased order processing time, improved nursing satisfaction (because of the former), increased documentation of pharmacist interventions, and improved access to care. [21][22][23][24][25]…”

Section: Potential Benefitsmentioning

confidence: 99%

Leveraging telecommuting pharmacists in the post–COVID-19 world

Martin¹

2020

Journal of the American Pharmacists Association

Self Cite

View full text Add to dashboard Cite

In response to the coronavirus disease 2019 (COVID-19) pandemic, many industries, including pharmacy, rapidly expanded the use of telecommuting workers to assure business continuity and address social distancing needs. Advances in electronic health records and telepharmacy over the past 2 decades enabled pharmacy leaders to easily adapt their practice models to allow for telecommuting alternatives during the pandemic. While these changes were generally intended to be part of the short-term response, the sustained expansion of telecommuting within the pharmacy profession merits further exploration. Documented experience with telepharmacy and telehealth indicate a wide array of clinical and operational pharmacist activities that could be conducted by telecommuters. In addition, experience with telecommuters in other industries suggests potential benefits ranging from improving pharmacists' work-life balance to mitigating postpandemic financial burden. Health care organizations should consider integrating part-time telecommuter pharmacists into contemporary practice models to address other frontline issues and facilitate ongoing expansion of clinical pharmacy services to meet emerging patient needs.

show abstract

Section: Potential Benefitsmentioning

confidence: 99%

Leveraging telecommuting pharmacists in the post–COVID-19 world

Martin¹

2020

Journal of the American Pharmacists Association

Self Cite

View full text Add to dashboard Cite

show abstract

“…The National Association of Boards of Pharmacy and the American Pharmacists Association both have definitions of “telehealth” or “telepharmacy” that address operations and regulatory considerations. 17,18 The American College of Clinical Pharmacy published guidance for clinical pharmacists providing CMM remotely via telehealth in alignment with the Standards for Practice of Clinical Pharmacists 19,20 …”

Section: Modifying Ambulatory Care Pharmacy Practicementioning

confidence: 99%

“…A comprehensive evaluation program is essential for the success and quality improvement of telehealth services 19 . A systematic review found traditional pharmacist telehealth programs in ambulatory care had an overall positive impact on outcomes related to laboratory value monitoring and achieving therapeutic goals 16 .…”

Section: Monitoring Clinical and Financial Outcomesmentioning

confidence: 99%

Ambulatory care practice in the COVID‐19 era: Redesigning clinical services and experiential learning

Mohammad

Berlie

Lipari

et al. 2020

J Am Coll Clin Pharm

View full text Add to dashboard Cite

The coronavirus disease (COVID‐19) has created a variety of challenges for health care professionals, including ambulatory care clinical pharmacists. High‐quality remote and minimal‐contact care has become a necessity. Ambulatory care clinical pharmacists around the nation have adjusted their practice. In many cases, this included implementation of telehealth programs for comprehensive medication management. The redesign of ambulatory care Advanced Pharmacy Practice Experiences (APPE) also required quick adaptation. In this paper, we describe the clinical practice and experiential education challenges encountered by an ambulatory care clinical pharmacist workgroup in a COVID‐19 “hotspot,” with an emphasis on solutions and guidance. We discuss how to adapt ambulatory care clinical pharmacy practices including methods of minimal‐contact care, reimbursement opportunities, tracking outcomes, and restructuring ambulatory care APPE. As ambulatory care clinical pharmacists continue to expand the services they provide in response to COVID‐19, we also describe opportunities to promote pharmacists as providers during times of pandemic and into the future.

show abstract

“…Access to telehealth resources will be essential to reach patients on home dialysis modalities to complete medication reconciliation and CMM services. Best practices for implementation of CMM via telehealth have been recently published and serve as an excellent resource for pharmacists starting these programs in nephrology practice 61 . The Kidney Care Choices models provide additional payments for a kidney disease education benefit, which can be provided by pharmacists as a qualified provider.…”

Section: Tools For Implementation Of Pharmacist‐based Care In Kidney mentioning

confidence: 99%

“… Note : The standards are adapted from successful Canadian models 61 and serve as a baseline for additional development by the newly formed Advancing American Kidney Health through Optimal Medication Management agenda. …”

Section: Next Stepsmentioning

confidence: 99%

Nephrology practice and research network opinion paper: Pharmacists' perspectives on the Advancing American Kidney Health initiative

Meaney

Manley²,

Pai

et al. 2020

J Am Coll Clin Pharm

View full text Add to dashboard Cite

Patients with chronic kidney disease (CKD) are at high risk for clinically significant medication therapy problems (MTPs) due primarily to the complex pharmacotherapy prescribed by numerous providers, and the significant changes in pharmacokinetic and pharmacodynamic properties of many medications due to their kidney disease. While MTPs are well recognized, pharmacists are not routinely involved in the health care teams that provide care for patients with CKD. The Advancing American Kidney Health initiative was announced in July 2019 and is poised to shift models of care in nephrology toward value‐based payment. This represents an opportunity for pharmacists to integrate into teams to improve quality of care and outcomes for patients with CKD. Pharmacists should engage in medication reconciliation, transitions of care, and medication‐focused kidney disease education programs within a comprehensive medication management (CMM) framework to optimize pharmacotherapy outcomes. To implement these services, pharmacists need to utilize certified pharmacy technicians, telehealth, interprofessional skills, and other tools in innovative ways. Current models of successful practice from Canada can serve as a template for United States‐based nephrology pharmacy practice. In this opinion paper, we characterize the current state of nephrology practice and identify significant opportunities for advancement. We propose metrics to evaluate pharmacy services and a framework for key stakeholder engagement which will be critical to advance the profession of pharmacy within nephrology. The Advancing American Kidney Health initiative offers a distinct opportunity to demonstrate the value of CMM provided by pharmacists in the nephrology arena to optimize patient care.

show abstract

Implementation and evaluation of comprehensive medication management in telehealth practices

Cited by 15 publications

References 50 publications

Leveraging telecommuting pharmacists in the post–COVID-19 world

Leveraging telecommuting pharmacists in the post–COVID-19 world

Ambulatory care practice in the COVID‐19 era: Redesigning clinical services and experiential learning

Nephrology practice and research network opinion paper: Pharmacists' perspectives on the Advancing American Kidney Health initiative

Contact Info

Product

Resources

About